2016
DOI: 10.18632/aging.100983 View full text |Buy / Rent full text
|
|

Abstract: Bedaquiline (a.k.a., Sirturo) is an anti-microbial agent, which is approved by the FDA for the treatment of multi-drug resistant pulmonary tuberculosis (TB). Bedaquiline is a first-in-class diaryl-quinoline compound, that mechanistically inhibits the bacterial ATP-synthase, and shows potent activity against both drug-sensitive and drug-resistant TB. Interestingly, eukaryotic mitochondria originally evolved from engulfed aerobic bacteria. Thus, we hypothesized that, in mammalian cells, bedaquiline might also ta… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
1
67
0

Publication Types

Select...

Relationship

0
0

Authors

Journals